Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

Compare

67.03

+0.15 (0.22%)

At close: Oct 17, 2025, 4:00 PM EDT

67.32

+0.29 (0.43%)

After-hours: Oct 17, 2025, 6:58 PM EDT

Halozyme Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	1,179	1,015	829.25	660.12	443.31	267.59	Upgrade
Revenue Growth (YoY)	34.97%	22.44%	25.62%	48.91%	65.66%	36.53%	Upgrade
Cost of Revenue	265.29	238.47	268.72	205.91	117.09	77.6	Upgrade
Gross Profit	913.38	776.86	560.53	454.21	326.23	189.99	Upgrade
Selling, General & Admin	167.47	154.34	149.18	121.63	50.32	45.74	Upgrade
Operating Expenses	230.71	225.38	220.46	164.77	50.32	45.74	Upgrade
Operating Income	682.67	551.48	340.07	289.43	275.9	144.26	Upgrade
Interest Expense	-17.98	-18.1	-18.76	-16.95	-7.53	-20.38	Upgrade
Interest & Investment Income	19.07	12.83	10	3.88	3.36	5.43	Upgrade
EBT Excluding Unusual Items	683.76	546.21	331.31	276.36	271.74	129.3	Upgrade
Merger & Restructuring Charges	-	-	-	-21.9	-	-	Upgrade
Gain (Loss) on Sale of Investments	8.37	10.93	6.32	-2.83	-2.26	-	Upgrade
Asset Writedown	-	-	-2.5	-	-	-	Upgrade
Other Unusual Items	-	-	13.2	-2.71	-20.96	-	Upgrade
Pretax Income	692.13	557.13	348.33	248.92	248.52	129.3	Upgrade
Income Tax Expense	134.85	113.04	66.74	46.79	-154.19	0.22	Upgrade
Net Income	557.28	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income to Common	557.28	444.09	281.59	202.13	402.71	129.09	Upgrade
Net Income Growth	65.22%	57.71%	39.31%	-49.81%	211.97%	-	Upgrade
Shares Outstanding (Basic)	124	127	132	137	141	136	Upgrade
Shares Outstanding (Diluted)	128	129	134	141	147	141	Upgrade
Shares Change (YoY)	-2.50%	-3.56%	-4.56%	-4.21%	3.77%	-1.99%	Upgrade
EPS (Basic)	4.48	3.50	2.13	1.48	2.86	0.95	Upgrade
EPS (Diluted)	4.37	3.43	2.10	1.44	2.74	0.91	Upgrade
EPS Growth	68.93%	63.33%	45.83%	-47.45%	201.10%	-	Upgrade
Free Cash Flow	540.69	468.37	373.28	235.3	297.98	52.95	Upgrade
Free Cash Flow Per Share	4.24	3.62	2.78	1.67	2.03	0.37	Upgrade
Gross Margin	77.49%	76.51%	67.59%	68.81%	73.59%	71.00%	Upgrade
Operating Margin	57.92%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Profit Margin	47.28%	43.74%	33.96%	30.62%	90.84%	48.24%	Upgrade
Free Cash Flow Margin	45.87%	46.13%	45.01%	35.64%	67.22%	19.79%	Upgrade
EBITDA	758.6	627.09	416.93	336.07	277.3	145.84	Upgrade
EBITDA Margin	64.36%	61.76%	50.28%	50.91%	62.55%	54.50%	Upgrade
D&A For EBITDA	75.93	75.61	76.86	46.64	1.4	1.58	Upgrade
EBIT	682.67	551.48	340.07	289.43	275.9	144.26	Upgrade
EBIT Margin	57.92%	54.32%	41.01%	43.84%	62.24%	53.91%	Upgrade
Effective Tax Rate	19.48%	20.29%	19.16%	18.80%	-	0.17%	Upgrade
Revenue as Reported	1,179	1,015	829.25	660.12	443.31	267.59	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q